Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung penetration of caspofungin into epithelial lining fluid
2006-004107-20Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Oct 2007
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of caspofungin in mycoses, sponsored by Medical University of South Carolina. Primary endpoint: Concentration of caspofungin in epithelial lining fluid. Started Oct 2007; status: completed.
02
Drugs
caspofungin
03
Conditions
mycoses
Beyond the preview
Go deeper on 2006-004107-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004107-20.